314. Brian Le Gette, Founder & CEO of Ammortal

Today, I'm joined by Brian Le Gette, founder & CEO of Ammortal.   A wellness technology company, Ammortal's immersive recovery chambers combine PEMF, red light, molecular hydrogen, breathwork, and meditation into a single therapeutic experience.   In this episode, we discuss building the future of regenerative wellness tech.   We also cover: Raising a Series A and scaling commercially Developing the product, pricing model, and partnerships Stacking cellular repair modalities with mind-body integration   Subscribe to the podcast → insider.fitt.co/podcast   Subscribe to our newsletter → insider.fitt.co/subscribe   Follow us on LinkedIn → linkedin.com/company/fittinsider    Website: www.ammortal.com  Locations: www.ammortal.com/locations  Commercial Inquiries: [email protected]   Partnerships: [email protected] Instagram: https://www.instagram.com/ammortal_official Facebook: https://www.facebook.com/ammortals    -   The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities.   Fitt Talent: https://talent.fitt.co Consulting: https://consulting.fitt.co  Investments: https://capital.fitt.co   Chapters:  (00:00) Introduction (01:20) Brian's background and entrepreneurial journey (02:40) What is Ammortal and the one-of-one category (02:55) The core modality stack and protocol design (05:10) Origin story (06:30) Positioning beyond wellness buzzwords (09:00) Why "tech doesn't heal—it aids self-healing" (11:30) Target customer: optimization-focused consumers (14:30) Distribution strategy (18:00) Pricing models and commercial partnerships (21:15) The experience design and musical cocoon concept (23:30) Education and onboarding for new users (25:30) Customer outcomes and use case versatility (27:35) Landing on "chamber" as the product descriptor (29:05) Long-term vision and R&D philosophy (31:15) The collaborative model for wellness innovation (32:45) Raising a Series A and scaling commercially (34:10) Conclusion